You are here

Takeda

With patent loss looming, Takeda knocks proposed Velcade copycats in FDA petition

With patent loss looming, Takeda knocks proposed Velcade copycats in FDA petition

Fierce Pharma

Flag link:

Seattle Genetics Drug Scratches Out Win In Hodgkin Lymphoma

Seattle Genetics Drug Scratches Out Win In Hodgkin Lymphoma

Forbes

Seattle Genetics

Hodgkin's lymphoma

Flag link:

Takeda set to open new German manufacturing facilities

Takeda set to open new German manufacturing facilities

BioPharma Dive

drug manufacturing

Flag link:

Takeda starts work on €40M plant to produce multiple myeloma drug Ninlaro

Takeda starts work on €40M plant to produce multiple myeloma drug Ninlaro

Fierce Pharma

drug manufacturing

Multiple Myeloma

Flag link:

Takeda, sporting a new-look portfolio, revs for Roche battle in ALK lung cancer

Takeda, sporting a new-look portfolio, revs for Roche battle in ALK lung cancer

Fierce Pharma

Flag link:

AbbVie, Novo Nordisk and Takeda Have the Best Reputations Among Pharma Companies According to Reputation Institute Global Pharma Reptrak® Study

AbbVie, Novo Nordisk and Takeda Have the Best Reputations Among Pharma Companies According to Reputation Institute Global Pharma Reptrak® Study

PR Web

Flag link:

Takeda pens GammaDelta Therapeutics $100M pact, with M&A option

Takeda pens GammaDelta Therapeutics $100M pact, with M&A option

Fierce Biotech

GammaDelta Therapeutics

gamma delta T cells

Flag link:

Takeda's Ariad deal pays off with blockbuster green light for Alunbrig

Takeda's Ariad deal pays off with blockbuster green light for Alunbrig

Fierce Pharma

Ariad Pharmaceuticals

ALK-positive non-small cell lung cancer

Flag link:

J&J, Takeda among interested in Brazil's Hypermarcas, sources say

J&J, Takeda among interested in Brazil's Hypermarcas, sources say

Yahoo/Reuters

Flag link:

About that pharma M&A comeback? Sorry. 2017's not bringing it—at least not yet

About that pharma M&A comeback? Sorry. 2017's not bringing it—at least not yet

Fierce Pharma

Ariad Pharmaceuticals

Flag link:

Takeda continues global R&D reboot with a new joint venture with PRA

Takeda continues global R&D reboot with a new joint venture with PRA

Endpoints

Flag link:

Takeda chops into Ariad staff, handing out about 180 pink slips as it revamps Boston ops

Takeda chops into Ariad staff, handing out about 180 pink slips as it revamps Boston ops

Endpoints

Ariad Pharmaceuticals

Flag link:

Takeda teams up with venture firm on drug discovery unit

Takeda teams up with venture firm on drug discovery unit

BioPharma Dive

drug development

Flag link:

Celgene, Takeda and Others Found in Breach of UK’s Pharma Code of Practice

Celgene, Takeda and Others Found in Breach of UK’s Pharma Code of Practice

RAPS.org

Flag link:

Tech-focused Takeda pilots Apple Watch trial to collect depression data

Tech-focused Takeda pilots Apple Watch trial to collect depression data

Fierce Pharma

clinical depression

Flag link:

Longer survival seen with Amgen's Kyprolis vs Velcade in myeloma study

Longer survival seen with Amgen's Kyprolis vs Velcade in myeloma study

Yahoo/Reuters

Multiple Myeloma

Flag link:

Takeda, TiGenix stem cell therapy shows sustained effect

Takeda, TiGenix stem cell therapy shows sustained effect

Fierce Biotech

Crohn's Disease

Flag link:

2 Big Reasons Exelixis, Inc. Soared 22% in January

2 Big Reasons Exelixis, Inc. Soared 22% in January

Motley Fool

Flag link:

On a deal spree, Takeda grabs Japanese cabo rights in $145M pact with Exelixis

On a deal spree, Takeda grabs Japanese cabo rights in $145M pact with Exelixis

Endpoints

Flag link: